Home
Browse
Search
Statistics
About
Usage
PMID: 21594776
Loo TW, Clarke DM
Repair of CFTR folding defects with correctors that function as pharmacological chaperones.
Methods Mol Biol. 2011;741:23-37.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
147
ABCC7 p.His1085Arg
X
ABCC7 p.His1085Arg 21594776:147:74
status:
NEW
view ABCC7 p.His1085Arg details
ABCC7 p.Gln1071Pro
X
ABCC7 p.Gln1071Pro 21594776:147:63
status:
NEW
view ABCC7 p.Gln1071Pro details
HEK 293 cells expressing the CFTR processing mutants, F508del,
Q1071P
, or
H1085R
, were incubated with media containing no corrector (-) or 0.05 mM VX-325 plus 0.015 mM corr-4a (+).
Login to comment
247
ABCC7 p.Val510Ala
X
ABCC7 p.Val510Ala 21594776:247:114
status:
NEW
view ABCC7 p.Val510Ala details
To improve the maturation efficiency of Cys-less CFTR, cysteines 590 and 592 were replaced with leucines (16) and
valine 510 was changed to alanine
(17).
Login to comment
252
ABCC7 p.Val510Cys
X
ABCC7 p.Val510Cys 21594776:252:97
status:
NEW
view ABCC7 p.Val510Cys details
ABCC7 p.Ala1067Cys
X
ABCC7 p.Ala1067Cys 21594776:252:147
status:
NEW
view ABCC7 p.Ala1067Cys details
The following protocols describe disulfide cross-linking between cysteines introduced into NBD1 (
V510C
) and the fourth intracellular loop in TMD2 (
A1067C
) of a F508del-CFTR processing mutant expressed in the presence or the absence of correctors.
Login to comment
263
ABCC7 p.Val510Cys
X
ABCC7 p.Val510Cys 21594776:263:30
status:
NEW
view ABCC7 p.Val510Cys details
ABCC7 p.Ala1067Cys
X
ABCC7 p.Ala1067Cys 21594776:263:38
status:
NEW
view ABCC7 p.Ala1067Cys details
The next day, add 0.17 mg of (
V510C
)/(
A1067C
)/ F508del-CFTR cDNA to sterile water to give a total volume of 7.65 ml.
Login to comment
282
ABCC7 p.Val510Cys
X
ABCC7 p.Val510Cys 21594776:282:61
status:
NEW
view ABCC7 p.Val510Cys details
Effect of correctors on cross-linking of CFTR mutant F508del/
V510C
(NBD1)/A1067C(TMD2).
Login to comment